cyclopentane has been researched along with Emesis in 4 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (50.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (25.00) | 29.6817 |
2010's | 1 (25.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Ariyasu, Y; Ishii, S; Itoh, Y; Komeda, T; Sanekata, M; Shimada, J; Yoshikawa, T | 1 |
Han, J; Kim, B; Kim, JC; Shin, HC | 1 |
Bannon, MJ; Carr, LA; Duncan, GE; Jarboe, CH | 1 |
Andrews, NC; Aust, JB; Lawton, RL; Schroeder, JM | 1 |
1 trial(s) available for cyclopentane and Emesis
Article | Year |
---|---|
Clinical note. Phase II study of 1-aminocyclopentanecarboxylic acid (NSC-1026) in patients with cancer.
Topics: Amino Acids; Clinical Trials as Topic; Colonic Neoplasms; Cyclopentanes; Evaluation Studies as Topic; Feeding and Eating Disorders; Head and Neck Neoplasms; Humans; Leiomyosarcoma; Male; Neoplasms; Rectal Neoplasms; Sarcoma; Testicular Neoplasms; Valine; Vomiting | 1970 |
3 other study(ies) available for cyclopentane and Emesis
Article | Year |
---|---|
Post-marketing safety and effectiveness evaluation of the intravenous anti-influenza neuraminidase inhibitor peramivir (I): a drug use investigation.
Topics: Acids, Carbocyclic; Administration, Intravenous; Adolescent; Adult; Aged; Antiviral Agents; Cyclopentanes; Diarrhea; Female; Guanidines; Humans; Influenza, Human; Japan; Male; Middle Aged; Nausea; Neuraminidase; Product Surveillance, Postmarketing; Time Factors; Vomiting; Young Adult | 2014 |
Subacute toxicity and toxicokinetics of CJ-10882, a type IV phosphodiesterase inhibitor, after 4-week repeated oral administration in dogs.
Topics: Administration, Oral; Animals; Area Under Curve; Atrophy; Body Weight; Cyclopentanes; Dogs; Dose-Response Relationship, Drug; Eating; Female; Hydrazines; Male; Phosphodiesterase Inhibitors; Salivation; Thymus Gland; Toxicity Tests; Vomiting | 2004 |
Central nervous system actions of 2,5-bis(3,4-dimethoxybenzyl) cyclopentyl amine, a peripheral dopamine blocking agent.
Topics: Amines; Animals; Cyclopentanes; Dogs; Dopamine; Dopamine Antagonists; Dopamine beta-Hydroxylase; Male; Mice; Norepinephrine; Tyrosine; Vomiting | 1980 |